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Impact of Biotechnology on Agriculture Productivity
ROGER A. KLEESE
Molecular Genetics, Inc., 10320 Bren Road East, Minnetonka, Minnesota 55343
Biotechno~ogy is a. div_erse array of technolog_ies which today are in various stages of evolution and development. To understand them and
~he potennal apphcanon of th~se technologies to agriculture, it is helpful to consider them in a historical perspective. In addition, it is

important to un?erstand the mterdependence of biotechnologies on traditional, well developed technologies.
_The commercial development of biotechnology is more difficult than imagined even as recently as five years ago. Also, the problems
bemg addressed generally deman? a n:iuc? _better underst~nding_ of the physiology and biochemistry of the plant and animal systems
under study. Nonetheless, there is a sigmfICant opportumty to impact production per seas well as lowering costs of production and
creating products with added value.
INDEX DESCRIPTORS: Agricultural biotechnology, commercial development, productivity research

Biotechnology has been given tremendous publicity and promotion. In fact, no other technology has been given the fanfare with a
promise to deliver so much, while yet in its infancy, as biotechnology.
This attention and these promises have attracted venture capital and
the interest of the Wall Street community. Over two hundred start up
biotech companies have emerged, most of them since 1978. This has
brought about an interesting mix of scientists and business people
often resulting in scientists with no previous business experience
becoming the business executives.
INVESTMENT IN BIOTECHNOLOGY RESEARCH
The business plans (which have varied in quality and depth) have
ranged from seeds to animal agriculture to industrial enzymes to
artificial sweeteners to human therapeutics, with the latter category
attracting the most attention. The diversity of the technologies
coupled with the diversity of applications have made it difficult to
follow and to understand these new businesses. Nonetheless, the
public has clamored for stock in many of these companies, with public
offerings raising over a billion dollars.
In addition to the start up firms, large corporations have also
invested heavily in biotechnology. These have been primarily the
human pharmaceutical and ag chemical companies and a few of the
larger seed companies. My point in detailing the above activity is to
indicate to you the tremendous commercial interest in these technologies. However, I want to make it clear that the research giving rise
to biotechnologies began in academic institutions and it continues today. Federal research funding has emphasized these areas as evidenced
by grants from National Science Foundation (NSF), National Institutes of Health (NIH), Department of Energy (DOE), Department of
Defense (DOD), and the United States Department of Agriculture
(USDA). Scientific publications abound with entire journals devoted
to these subjects. Universities have been active in establishing
curriculum majors, institutes or centers with the objective of providing focus and organization for biotechnology teaching and research.
Chairs in molecular biology are now found at several universities. One
can attend a large number of an ever increasing spectrum of biotechnology conferences. Research in both the public and private sector
continues to be stimulating and exciting.

BIOTECHNOLOGY -

DEFINING RESEARCH AREAS

Biotechnology is not a precise term, in fact, there is not a good term
which embraces and defines the family of technologies. Traditional
fields of biology such as medicine or plant and animal breeding can
certainly be understood as biotechnologies, but generally are not
included under the modern day umbrella of biotechnology. For our

purposes I would like to include three sets of technologies. These three
technologies are genetic transformation, monoclonal antibodies and
plant cell and tissue culture. The common thread which runs through
these three technologies is the genetic manipulation made possible by
them. Each of the technologies gives rise to a broad range of
applications.
Genetic Transformation
The first technology is dependent upon molecular biology, especially cloning of genes and their transfer to new organisms. This
technology has been made possible by the discovery of a family of
enzymes which can be used in a precise fashion to remove pieces of
DNA (deoxyribonucleic acid). A skilled molecular biologist can use
these enzymes as scissors and glue to cut apart a strand of DNA and
insert new pieces between the cut ends. Thus, the term recombinant
DNA. Initial work with recombinant DNA was reported in 1973.
Since the genetic code is essentially universal, it is theoretically
possible to identify and remove a gene from one organism and to place
it into another. In addition to the actual insertion and manipulation of
the new gene, it's also possible to modify the level of expression of that
gene. One can obtain extremely high levels of expression of a cloned
gene resulting in tremendous amounts of gene product being made.
Many of the commercial applications play on the high level of
expression of a foreign gene generally placed in a bacterium. The
bacterium becomes a factory for the production of the new gene
product. For example, human insulin and human growth hormone
come from E. coli that has been transformed with either the human
insulin gene or the human growth hormone gene, respectively.
Monoclonal Antibodies
The second technology, which I would include under the umbrella
of biotechnology, is the making of monoclonal antibodies, known as
hybridoma technology. When an animal's immune system is challenged by something foreign such as during infection or by a
vaccination, a whole host of antibodies is produced. The entity
stimulating the immune system is referred to as an antigen or an
immunogen. Antigens are typically protein, but they could be other
molecules of various composition. Although a variety of antibodies
with varying degrees of specificity are produced in response to an
antigenic stimulation, the particular cells producing antibody are
each quite specific in the kind of antibody being made. Thus, the
range of antibodies comes from a range of cells each producing a single
kind of antibody. It's possible to isolate these individual cells and to
fuse them with long living cells, generally myeloma cells, creating
what we call hybridomas. Each hybridoma has the ability to produce a
single kind of antibody and if one searches through the range of
hybridomas that come from a single antigenic response one finds
certain hybridomas which produce extremely specific antibodies.
These antibodies, referred to as monoclonal antibodies, have a variety
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of uses because of their specificity. Among those uses are diagnostics
and therapeutics for specific diseases and certain chemical or industrial
purification applications. Monoclonals were first reported in 1975.
Plant Cell and Tissue Culture
The third technology which I am including is th of plant cell and
tissue culture. This is by far the oldest of the three technologies. In
fact, the earliest literature reports of growing plant cells in culture are
found just before the turn of the century in the late 1890s. Tissue
cultures have been used for a number of years to propagate ornamentals such as orchids, and to clean up virus infections in vegetatively
propagated crop species such as woody ornamentals or berry plants.
Tissue cultures are now being used in a variety of ways including
selecting for useful traits and as recipient cells for gene transfer. Cell or
tissue culture manipulations are very species dependent. It's possible
to grow some species as individual cells and to regenerate whole plants
from those cells whereas other species are difficult to maintain even as
clumps of cells. We find in general that the cereals have been difficult
to culture and especially difficult to manipulate as individual cells.
The opposite is true for such species as tobacco or carrots in which any
part of the plant can be cultured and regenerated into plants.

chemicals, herbicides and insecticides, and commercial fertilizers.
Contributions from biotechnology will have to be sizable before
adding it to this list.

Crossing Species Boundaries
The ability to genetically cross species barriers is one of the more
unique properties. Plant breeders are generally constrained by working either within the crop species which they are trying to improve or
at best using some very closely related relatives as sources of important
genes such as those that might provide resistance to plant diseases. For
example, it has been possible to cross closely related grass species to
some of the cereals. Even interspecific crosses between cereals such as
wheat and barley are possible, although it is not possible to cross either
of those species with corn, also a cereal. Genes from broadleaf crop
species such as tomatoes, potatoes and soybeans have not been
available for cereal crop breeders. Using molecular biology techniques, it is possible to identify genes in any species, plant or
otherwise, and to transfer them into a new plant species. We are still
quite limited in the range of species where this is possible. Also, we're
limited in our ability to isolate genes. Gene transfer in most farm
crops species has not been accomplished, but we presume that the
technology will be developed.
EFFICIENCY OF AGRICULTURAL PRODUCTION
I will return to a further discussion of these biotechnologies, what Expression of Valuable Genes
A second unique feature of the new biotechnology is the opportunithey are and what they are not, and especially their relationships with
ty
it affords us to bring about high levels of expression of valuable
traditional fields of science. I want to turn now to a brief consideration
of agricultural productivity. I would like us to think in terms of genes. I have previously made reference to two examples of this,
efficiency of agricultural production which some are referring to as human insulin and human growth hormone. Examples in animal
productivity rather than simply thinking of production per se. agriculture are bovine growth hormone, which causes increased milk
Because of where you reside, I am sure you're well aware of the production, as well as certain antiviral or immune stimulating agents
financial crisis faced by many Iowa farmers and local businesses selling such as the interferons. In theory, any gene could be made to express
to those farmers. There are several reasons for this including global high levels of its gene product.
recession in the past five or six years as well as the rising value of the Unique Business Opportunities
I believe another unique characteristic of biotechnology will be the
dollar, both of which have resulted in decreasing demand for U.S.
farm commodities abroad. In the midst of this we have produced in opportunity to cross traditional agricultural business areas. I'd like to
excess of the demand, and overproduction, especially of corn, wheat give a couple of examples of this. Using either selections in plant
and soybeans, has become a major problem. An immediate reaction to tissue culture or molecular biology approaches, it is possible to
this by some is to reduce spending for agricultural research. I think manipulate biochemical composition such as protein quality. Proteins
this would be a mistake. I will not use this time to deal with policies of are composed of some twenty different amino acids, ten of which are
agricultural research, but I do want you to know that my premise for considered essential to swine and poultry. That is, swine and poultry
the comments that I will make is that increasing efficiency of cannot make these amino acids. To formulate a balanced ration for
production generates a positive economic impact for society. The either group of livestock, it is necessary to supplement corn with
United States has a preeminence in world agriculture which has come another source of protein, usually soybean oil meal, since corn protein
from research leading to more productive biological, chemical and is deficient in two essential amino acids, lysine and tryptophan.
mechanical technologies coupled with more efficient managerial Improving protein quality in corn impacts the feed supplement
skills. We should support good agricultural research which will business by reducing the need for soybean oil meal. Seed would be
benefit both consumers and producers. This requires that we think used to deliver improved protein quality and essentially to deliver the
rather broadly as we define the agricultural research mission. It's balanced ration.
important to be aware of both national and international economic
Another example of merging different businesses involves the use of
forces. We do market products in a world economy. We need to seeds to deliver animal biologicals. Viruses are composed of a core of
provide some protection for our own production capacity. It is DNA surrounded by a coat of several proteins. When the virus invades
necessary, also, to be sure that agricultural research is concerned about an animal, the animal's immune system responds by producing
the health and safety of agricultural producers and the consumers. antibodies generally against one or two predominant proteins found in
Furthermore, the environment and the quality oflife in rural areas also the coat of the virus. It is, in fact, possible to stimulate good antibody
should be considered in the agricultural research mission.
production by simply injecting an animal with the viral protein which
raises the protective immunologic response. The molecular biology
approach to creating a vaccine is to isolate a gene which codes for the
immunogenic protein, transfer that gene into a cell type which will
BIOTECHNOLOGY - ITS UNIQUE QUALITIES
serve as a factory to manufacture large quantities of the gene product
I would like to return now to a further discussion of biotechnology, and then to isolate the protein for use as the vaccine. An extension of
what it is and what it is not, and its relationship to other areas of this technology would be to remove the viral gene which codes for the
science. Much about these new technologies is not unique. Today they immunogenic protein and place that directly in a plant cell. If those
may be thought of simply as the new technologies which may some plant cells were the cells of a kernel of corn, we could imagine corn
day be added to an impressive list of proven agricultural technologies. serving as the delivery vehicle for an oral animal vaccine. Consider
This list includes hybrid seeds, especially corn, the agricultural crop plants for delivering not only vaccines, but improved nutritional
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quality of protein, of c~r~hydrate or fut, as well as hormones which
would enhance feed effK1ency and carcass quality.
TRADITIONAL BIOLOGICAL RESEARCH
SUPPORTS BIOTECHNOLOGY
Applicati~~s of biotechnology are very dependent upon our knowledge m tradmonal areas of science. We have tended to focus on the
te~hnologies per se rat_her than thinking of the supporting fields of
soence that are essennal for the applications that we would like co
mak~. Even my comments have focused on the technologies, and
certa_mly n:ost of what ~ou read would cause you to think only of the
man1pulat1ve technologies and not of the traditional areas of science
that must support these applications. To illustrate this, I would like to
refer to Ol.~r own company's experience in applying some of these new
technologies. We have both a plant biology and animal health care
research organization.
Plant Biology
. Within the plant research group we have people trained in cell and
tissue culture, as well as people who have strong backgrounds in
molecular_biol_ogy. We think of both of these as genetic manipulative
technologies smce they are really skills with a whole host of practices
and procedures for manipulating plant cells or individual genes. But
no one in our group in the course of their formal education majored in
cell culture nor in molecular biology. Instead, the scientists' backgrounds are in biochemistry, physical biochemistry, genetics, physiology and microbiology. One of the projects we have pursued is the
improvement of protein quality in corn by elevating the levels of
lysine and tryptophan. Our approach for doing this has been to select
for high levels of these amino acids in cell cultures in much the same
way that a microbiologist would select for a particular mutant by
plating millions of cells (Hibberd, et al., 1986). There is a considerable amount of skill and experience needed to manipulate plant cells
in culture. It's not a trivial exercise and it's far more complex than
growing bacteria or yeast. But even before one can consider the actual
manipulations of the cultures, there has to be a selection strategy
which is based upon an understanding of the biochemistry of the
system under selection. It has been the understanding of the biosynthetic pathway for tryptophan which allowed us to do our selection
work, to know there is an enzyme which can be deregulated and in so
doing should lead to an overproduction of tryptophan.
Animal Biology
In our animal health research group the principal biotechnologies
which we have are the cloning, transfer and expression of genes and
the isolation of monoclonal antibodies. Our commercial interests are
in dealing with infettious diseases and in promoting growth and
performance in livestock. Because of this, the scientific disciplines
that our people come from are virology, veterinary medicine, immunology, biochemistry, microbiology and endocrinology. We have
not always fully realized the importance of these traditional disciplines
as they would impact the development of products. When we opened
our doors, one of our primary product goals was to produce vaccines to
infectious viral diseases in livestock by using a molecular biology
approach. We assumed that if we were able to isolate the appropriate
viral gene coding for the best immunogen and were then able to
transfer that into bacteria and bring about a high level of expression of
that gene, we would have an antigen that would induce the appropriate immune response. Each step of the molecular biology presented a
considerable challenge to us. I recall a time when we had been able to
get viral genes inserted into E. coli but were struggling with getting
significant levels of expression. We realized that we needed several
percent of the cell protein to be made from the viral gene. Otherwise,
we did not have a commercially viable product. I am sure if someone
had come to us at that time and offered to sell us "an expression vector"

that would gi".e high levels of expression, perhaps 5-6% protein we
would have pa1~ dearly for it. But in time we were able to manip~late
the co~trol reg1~ns of the g_enes so we did obtain this high level of
expression. Havmg done this we set about to immunize, first small
'.1n1mals and then large _ani_mals, to ascertain the degree of immunologlC response and to see if, m fact, we could protect animals. We have
found this to be a very difficult exercise and now realize there is so
much that "':"e do no~ understand about stimulating a good immune
response with a particular ~tigen. Basic immunology is really the
ar~ w~ere we ~eed to focus 1f we are to use this method of producing
effKacious vaccmes.
NEW PRODUCTS FROM
BIOTECHNOLOGY -THE PROMISE
What are the promises of things to come from biotechnologies?
Jack Doyle ( 1985) writes, "These technologies promise to remedy all
manner ?f agricultural problems confronting every society attempting
co_ feed itself. In raw food crops, nutritional qualities can be mainta11:ed or carefully improved, a wider variety of nutritionally sound
frultS and vegetables might be possible and the threat of nutritional
erosion through breedi~g can be overcome or eliminated. New crops
may be genetKally designed that won't require pesticides, or which
will use less water and make their own fertilizer. Livestock can be
engineered to produce more and better quality meat, milk, and eggs
o? less feed. F~m an~mals can also be helped to genetically fight off
disease and assiste~ m other ways so they won't need antibiotics,
hormone~, or _vaccmes. A n~w and better use of ecological pest
controls m agriculture may reign because of better biological understanding made possible through biotechnology." As you can see, some
people have great expectations for biotechnology.

NEW PRODUCTS FROM
BIOTECHNOLOGY - REALITY
What, in fuct, has been the impact of these technologies on
agriculture to date? The answer is, very little. There are several
potential new crop varieties which have come from tissue cultures
which appear to be spontaneous genetic changes resulting in some
improvement in the original variety.
Herbicide Resistance
The rationale for developing herbicide resistant crop varieties is to
broaden the use of a particular herbicide so it can be applied to crops
which would otherwise be sensitive. The most positive application of
this technology involves the use of new compounds with much lower
toxicity where smaller quantities of the chemical are applied. There
are several examples of using either tissue culture or molecular biology
techniques to incorporate herbicide resistance into crop varieties.
However, most of these are with tobacco which most scientists use as a
model system. Only a couple of the species are of furm crops, with one
of them being corn. Varieties of these species are still a few years from
the market.
Disease Resistance
There are several laboratories using tissue culture to select for
resistance to certain plant diseases, especially those diseases which
produce toxins. Introducing a toxin into the media would seem to be a
reasonably effective means of selecting for cells which are able to grow
in the presence of that toxin, thus providing some opportunity for
eventually selecting plants which are resistant to the disease and the
toxin. There has been some limited success with this approach
(Gengenbach and Green, 1975 ). Using the same cell culture selection
technique to select resistance to diseases which do not produce toxins
poses a somewhat more complex task. Improving disease resistance
using molecular biology techniques is not very feasible at this point.
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of basic plant biology, that is, plant biochemistry, physiology and
We have little information which would allow us to obtain genes genetics, which would be most helpful in understanding host pathoconditioning resistance to races of plant pathogens. Even if the genes gen relationships, host insect pest relationships, fertilizer nutrient
were available, pathologists would question whether this approach demands of plants, the uptake and utilization of those nutrients, as
would be a satisfactory long-term means of delaying with a plant well as the biochemical components useful in animal nutrition. I
pathogen. Plant breeders have for several decades selected for resist- think it's this knowledge gap which will limit our ability to improve
ance to specific races of plant pathogens by selecting for an individual crop varieties using some of the new technologies. In contrast there
gene which confers resistance to a race of the pathogen. In time the has been at least twenty years of basic research on bacteria and
pathogen mutates and a new virulent race evolves. This has been a mammals that has laid the groundwork for medical applications of
never ending cycle and one which pathologists and plant breeders have
engineering.
attempted to avoid by breeding for some lower level of resistance genetic
There is another fundamental reason why these technologies are not
conditioned by multiple genes and thereby reducing the opportuniry likely to impact plant agriculture as soon as they will impact
for a highly virulent form of the pathogen to emerge.
medicine. Many of the medical applications of biotechnology involve
the production of large quantities of a gene product. These gene
Insect Resistance
products are to be used either as therapeutic or diagnostic reagents.
Work in the insect control area has been primarily centered on the
Bacillus thuringiensis toxin. This work is today yet limited by the The molecular biology objective in manipulating these genes is
number of plant species which can be transformed using a molecular simply to elevate the expression of the gene to the highest level
biology gene transfer technique. In general, very little is understood possible within the limits of the cell producing the gene product. ln
of the biochemical basis for insect resistance and as a result we're faced general, the molecular biology approaches that we imagine in crop
with a situation not unlike that in dealing with plant diseases, where plants will require that the gene be expressed in the right tissue at the
we are not able to chemically identify those genes which would be right time and in appropriate quantities to bring about the desired
effect. Genetically engineered crop varieties will no doubt come from
candidates for gene transfer.
already elite crop varieties which can be thought of as rather finely
Improved Fertilizer Efficiency
tuned biological systems with many good qualities to which we are
. Perhaps one of the most widely publicized potential applications of simply trying to add an additional trait. There is a significant chance
b10ti:chnolo?Y to crop agriculture is genetically altering plants so they that adding another gene for another trait could disrupt the system.
provide their own source of nitrogen. This would seem on the surface Furthermore, it will not be easy and straightforward to regulate the
to be especially useful for cereals where nitrogen is the nutrient of amount, time and location of expression of the genes we choose to
greatest need. However, there are rather major problems. First, there manipulate. In short, because of the end effect desired 1 believe the
ru:e a number ?f genes responsible for fixing nitrogen. The molecular task for genetically manipulating crop varieties will be much more
b10logy _exerose of getting all of these genes into a package and
demanding than that of producing human therapeutics.
transferring them en masse would be difficult. In addition, there are
physical and chemical demands of the system such as anaerobic
conditions required for one of the principle enzymes.

Stress Tolerance
. We oft~n. see st~ess t?le~ce as something which people are
mtere.sted m 1mprovmg with b10technology. However, it has been my
~nen~e that the stress most often faced in Midwestern agriculture
varies with the season and the location and is quite unpredictable. ln
some years and loca~ions _excessive moisture creates a stress problem.
In those ~e locations m other years deficiency of water creates a
pro~le~. H1~h temperatures may accentuate draughty conditions.
Yet 1t 1s poss1~le to have draughty conditions without high temperature. Cool spnng temperatures are yet another stress condition. If one
c~ defin~ the ~icular stres~ environment such as, for example,
salme_ soils, I _believe there _is. some opportunity to manipulate
breeding matenals so that var1et1es can be selected which withstand
that _specific st_ress. ~o deal with more general kinds of stress
condmons, I think, will be difficult.
Nutritional Quality
By using cell cultures we have been able to elevate the levels of
tryptophan sufficiently high in some breeding materials so there
would be no need for additional tryptophan in swine rations. Using
the same a~proach, we have attempted to elevate the level of lysine as
well but. without success. Over the past year and a half we have been
attemptmg to.~ a molecular biology approach to elevate lysine. We
feel very. ~s1t1ve about this approach and about the long term
opportun1t1es for manipulating nutritional quality. However, there is
a great need to understand more about the biochemistry and physiology of the plant so we can more efficiently make these manipulations.

LIMITATIONS TO PROVIDE NEW PRODUCTS
In general we have a tremendous need for a greater understanding

APPLICATION TO ANIMAL AGRICULTURE
I would like to make a few comments about four product areas in
animal agriculture - diagnostics, therapeutics, vaccines and growth
~ormones . As m~ntioned previously, there are already several diagnost!Cs for animal diseases based upon the use of monoclonal antibodies.
There are dozens of monoclonal antibody based diagnostic kits on the
n:arket for human diseases. The task of producing these diagnostic
kits does not seem to be difficult. However, the animal markets are
not large and it is questionable just how many will be developed
because of the small market size.
Monoclonals al~o hav~ been developed to be used as therapeutic
agents to treat ammal diseases, but again, cost of goods, that is the
cost of monoclonal antibody, may be so high that it will limit the
number of monoclonal antibody therapeutic products.
1:Jsing molecul~r biology to produce vaccines by cloning viral genes·
whICh code for 1mmunogenic proteins have generally not been
successful. Although the gene product, the immunogenic protein,
can be s~own to h_ave exactly the same amino acid sequence as that of
the native protem apparently three-dimensional conformational
changes cause these proteins to be poor immunogens. Out of some
twenty viral diseases which have been studied using this technique,
there are only a couple where efficacious vaccines have been produced.
Producing animal growth hormones would seem to be an area
where the use of molecular biology will be counted as a technical
success. Th<:re is a consid~rable amount of work proceeding on several
of the bovme and porcme growth hormones with a number of
~adem!c institutions ~? commercial firms pursuing their application t_o improve f~d eff1C1ency, rate of gain and carcass quality, as well
as mil~ production. Products from this area of research represent
potent1ally the largest animal agriculture market and therefore, have
attracted the most research activity.

IMPACT OF BIOTECHNOLOGY

BIOTECHNOLCXiY - PUBLIC VERSUS
PRJVATE RESEARCH
I have attempted up to this point to give you a thumbnail sketch of
my impressions of some of the technical aspects of biotechnology and
how I see them impacting agricultural productivity. There are a
number of nonscientific issues which need to be addressed because I
believe there are other aspects of agriculture or agricultural research
which will also be impacted by this technology. The first of these is a
question about who will be doing the research and, in particular, what
will be the role of public agricultural research institutions. In the past,
particularly in the first half of the Twentieth Century, land grant
institutions and federal researchers in the USDA provided the major
input into improved technologies and products for agriculture. The
agricultural extension service was a vital link in transmitting this
information from those institutions out to the farm. Since World War
II we've seen the growth of the hybrid seed corn industry, the use of
commercial fertilizers has become routine, and the advent of agricultural pesticides, especially herbicides, has led to their use as a common
agricultural input. The animal health care industry has grown up
during that time providing products for the control or prevention of
disease such as vaccines and antibiotics, and growth performance
products which alter metabolism thus improving feed efficiency and
carcass quality. These have become common in the marketplace.
Research efforts by private industry have grown tremendously during
this time, generally with greater focus toward applying existing
knowledge or technologies for the development of commercial products. Best estimates suggest the public sector accounted for 2/3 of the
research in the early 1950's with this proportion of research shifting to
the private sector by the early 1980's (Ruttan, 1986). The public
agricultural research units have continued to work on a mix of so
called basic and applied research projects. They've also assumed some
responsibility for working in those applied areas where commercial
incentives are not sufficient to generate private research efforts.
The new molecular biology based technologies as well as the
monoclonal antibody technology were given birth outside either the
public or private agricultural research organizations. Because of this
there is a new mix of players working on projects that many times will
directly impact agricultural research. We find an increasing share of
agricultural research conducted outside colleges of agriculture as well
as increased funding in these colleges coming from sources outside the
USDA or state appropriations to experiment stations. This new mix of
nonland grant institutions coupled with massive investments in start
up biotechnology firms and large corporations is creating a very
different picture of agricultural research activity. What will be the
interaction and communication among the various research groups?
What restructuring will take place? How will the role of the
agricultural experiment stations and the USDA evolve and be shaped?
Will all this emphasis on biotechnology distract us and severely curtail
necessary research in traditional disciplines?

BIOTECHNOLCXiY- PUBLIC ACCEPTANCE
A second issue is the public's comfort level with the use of these new
technologies. Biotechnology has generated some fear and opposition
because of its ability to take genes from one species and put them into
another, something that nature has prevented in the past. Critics fear
the release of particularly virulent forms of new organisms with
unanticipated effects. They worry about the adulteration of food or
feedstuffs from materials produced in high levels by organisms which
have been engineered with that capability. Those involved in biotechnology argue that genetically modified organisms will be appropriately disarmed or that we are, after all, simply dealing with natural
genes that produce naturally occurring gene products and that, in
fuct, there is opportunity for greater safety. An example would be in
making plants resistant to diseases rather than developing chemicals
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to control diseases. Nonetheless, concerns have generated considerable federal, some state, and even some municipal activity to provide
an appropriate regulatory framework for evaluating the safety of the
research activity itself as well as the products being developed. At the
federal level, a presidential commission has involved some fifteen
federal agencies such as the Environmental Protection Agency (EPA),
National Institutes of Health (NIH), National Science Foundation
(NSF), the United States Department of Agriculture (USDA) and the
Food and Drug Administration (FDA) to come up with a comprehensive, yet manageable set of regulatory policies. It is not clear today
what regulatory issues will need to be faced in gaining approval to
work in particular research or product areas.

BIOTECHNOLCXiY - SOCIAL AND ECONOMIC ISSUES
Finally, there are socio-economic issues to consider because of some
of the biotechnology derived products. We are already observing some
of the farmer's concerns about bovine growth hormone. When
injected into cows, this growth hormone can improve milk production by as much as 40%. Certain dairy farmers are saying this is a risk
to milk prices and their own financial security because of an even
greater overproduction of milk. Those companies working on this
product argue that the bovine growth hormone is farm operation size
neutral. Small farmers as well as large farmers can use the product.
Nonetheless, a group of farmers in Wisconsin have banded together
fighting the approval of the product and taking the stand that they
will not use it. The European Common Market is considering a
complete ban on this and similar products.
If milk consumption is only maintained and if this product does
increase milk production, then it is estimated that milk prices will fall
and the number of dairy cows and dairy farms will also decline. Which
farmers will be most affected? How many farms will actually disappear? What will be the alternative opportunities for employment for
dislocated farmers?

SUMMARY
I've tried to give you some of my impressions about the nature of
biotechnology and its possible impact on agricultural productivity as
well as attempting to comment on some of the more significant issues
which I think are going to be before us. We don't, at this time, know
just how great the impact from these technologies will be. At times
promises of new products or technologies are in excess of what the
biotechnologies can deliver. On the other hand, there is significant
opportunity for some revolutionary products. No doubt we will see a
mix of products which represent slight improvements on traditional
product concepts together with products that we have yet to conceive.
Agriculture is changing for reasons other than biotechnology, and it's
going to change because of biotechnology. The challenge is to
participate in those changes and try to direct them to the benefit of
society.
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